The present female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Togo is 21.2%, a decrease of 0.1% (-0.5%) compared to 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Togo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Togo
Female CVD, cancer, diabetes or CRD
More indicators for Togo
Out-of-pocket expenditure PPP per capita
intl dollar90
+intl dollar5
(2021)
Newborns protected against tetanus
83%
-2%
(2022)
Female wasting in children
5.3%
-0.3%
(2017)
Birth registration
82.9%
+4.9%
(2017)
Female prevalence of HIV
0.8%
0%
(2022)
Contraceptive modern method prevalence
21.4%
+4.1%
(2017)
Togo Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 21.2% | -0.1% |
| 2018 | 21.3% | -0.3% |
| 2017 | 21.6% | -0.6% |
| 2016 | 22.2% | -0.4% |
| 2015 | 22.6% | -0.2% |
| 2014 | 22.8% | -0.3% |
| 2013 | 23.1% | -0.3% |
| 2012 | 23.4% | -0.2% |
| 2011 | 23.6% | 0% |
| 2010 | 23.6% | -0.3% |
| 2009 | 23.9% | -0.2% |
| 2008 | 24.1% | -0.2% |
| 2007 | 24.3% | +0.1% |
| 2006 | 24.2% | +0.1% |
| 2005 | 24.1% | 0% |
| 2004 | 24.1% | -0.1% |
| 2003 | 24.2% | +0.1% |
| 2002 | 24.1% | +0.2% |
| 2001 | 23.9% | +0.3% |
| 2000 | 23.6% |